Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Ramos

Showing results (91-100 of 657) with videos related to

Pageof 66
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 18, 2017
Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State ValuesKim Rand-Hendriksen, Juan Manuel Ramos-Goñi, Liv Ariane Augestad, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 24, 2004
Skin tumors in patients aged 90 years and olderJosé C Pascual, Isabel Belinchón, José Manuel Ramos, et al.
Archivos De Bronconeumologia|May 27, 2009
[Spanish scientific research output on tuberculosis indexed in MEDLINE, 1997-2006]José Manuel Ramos, Mar Masiá, Sergio Padilla, et al.
Health Science Reports|December 22, 2025
Pyoderma Gangrenosum in Spain: Clinical Features, Therapeutic Management, and Outcomes in a 32-Patient Case SeriesJosé-Manuel Ramos-Rincón, Jorge Esteban-Jarabo, Marina Senent, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 8, 2020
An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y valuesKoonal K Shah, Juan Manuel Ramos-Goñi, Simone Kreimeier, et al.
Nature Reviews. Rheumatology|April 14, 2010
Targeted therapy for systemic sclerosis: how close are we?Manuel Ramos-Casals, Vicent Fonollosa-Pla, Pilar Brito-Zerón, et al.
Lupus|July 7, 2009
Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 casesManuel Ramos-Casals, M J Soto, M J Cuadrado, et al.
Medicina Clinica|May 1, 2023
[Non-tuberculosis mycobacterial lung disease: Analyses of 62 cases]Alicia Ferradas, Paula Martí-Ortega, José-Manuel Ramos-Rincón, et al.
Medicina Clinica|March 26, 2013
[Cardiovascular disease: a view from global health perspective]Alejandro Salinas Botrán, José Manuel Ramos Rincón, Miguel de Górgolas Hernández-Mora
Scientific Reports|October 21, 2025
Incidence and predictors of mortality among persons with rifampicin-resistant tuberculosis and HIV in MozambiqueEdy Nacarapa, Benedita Jose, Isabelle Munyangaju, et al.
Pageof 66

Showing results (91-100 of 657) with videos related to

Sort By:
Pageof 66
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 18, 2017
Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State ValuesKim Rand-Hendriksen, Juan Manuel Ramos-Goñi, Liv Ariane Augestad, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 24, 2004
Skin tumors in patients aged 90 years and olderJosé C Pascual, Isabel Belinchón, José Manuel Ramos, et al.
Archivos De Bronconeumologia|May 27, 2009
[Spanish scientific research output on tuberculosis indexed in MEDLINE, 1997-2006]José Manuel Ramos, Mar Masiá, Sergio Padilla, et al.
Health Science Reports|December 22, 2025
Pyoderma Gangrenosum in Spain: Clinical Features, Therapeutic Management, and Outcomes in a 32-Patient Case SeriesJosé-Manuel Ramos-Rincón, Jorge Esteban-Jarabo, Marina Senent, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 8, 2020
An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y valuesKoonal K Shah, Juan Manuel Ramos-Goñi, Simone Kreimeier, et al.
Nature Reviews. Rheumatology|April 14, 2010
Targeted therapy for systemic sclerosis: how close are we?Manuel Ramos-Casals, Vicent Fonollosa-Pla, Pilar Brito-Zerón, et al.
Lupus|July 7, 2009
Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 casesManuel Ramos-Casals, M J Soto, M J Cuadrado, et al.
Medicina Clinica|May 1, 2023
[Non-tuberculosis mycobacterial lung disease: Analyses of 62 cases]Alicia Ferradas, Paula Martí-Ortega, José-Manuel Ramos-Rincón, et al.
Medicina Clinica|March 26, 2013
[Cardiovascular disease: a view from global health perspective]Alejandro Salinas Botrán, José Manuel Ramos Rincón, Miguel de Górgolas Hernández-Mora
Scientific Reports|October 21, 2025
Incidence and predictors of mortality among persons with rifampicin-resistant tuberculosis and HIV in MozambiqueEdy Nacarapa, Benedita Jose, Isabelle Munyangaju, et al.
Pageof 66